Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Elicio Therapeutics, Inc. (ELTX) had Return on Tangible Equity of -125.89% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-11.21M |
|
-- |
|
-- |
|
$10.74M |
|
$-10.74M |
|
$-0.47M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-10.74M |
|
$-10.42M |
|
12.95M |
|
12.95M |
|
$-0.87 |
|
$-0.87 |
|
| Balance Sheet Financials | |
$20.93M |
|
$0.43M |
|
$7.21M |
|
$28.14M |
|
$11.41M |
|
-- |
|
$7.83M |
|
$19.24M |
|
$8.90M |
|
$8.90M |
|
$8.90M |
|
15.97M |
|
| Cash Flow Statement Financials | |
$-10.12M |
|
-- |
|
$10.33M |
|
$19.49M |
|
$19.73M |
|
$0.24M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-125.89% |
|
|
Return on Tangible Equity |
-125.89% |
-39.83% |
|
-125.89% |
|
$0.56 |
|
$-0.78 |
|
$-0.78 |
|